MLchartDataset catalogue

autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine

Term · Oncology and biomedicine · MLC-T-ONC-011679

A cell-based cancer vaccine consisting of hybrid cells created by electrofusing allogeneic dendritic cells (DCs) and autologous lymphoma cells with potential immunostimulating and antitumor activities. Upon administration, autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine may stimulate the immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against specific autologous lymphoma-associated antigens, resulting in lymphoma cell apoptosis.

Table 1. Record
IdentifierMLC-T-ONC-011679
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011679",
  "term": "autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cell-based cancer vaccine consisting of hybrid cells created by electrofusing allogeneic dendritic cells (DCs) and autologous lymphoma cells with potential immunostimulating and antitumor activities. Upon administration, autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine may stimulate the immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against specific autologous lymphoma-associated antigens, resulting in lymphoma cell apoptosis.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-lymphoma-cell-allogeneic-dendritic-cell-electrofusion-hybrid-vaccine/"
}

Record 3,015 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.